Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
about
Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Amelioration of streptozotocin‑induced pancreatic β cell damage by morin: Involvement of the AMPK‑FOXO3‑catalase signaling pathway.
P2860
Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Poly(ADP-Ribose) Polymerase-1 ...... ls in Retina of Diabetic Rats.
@en
type
label
Poly(ADP-Ribose) Polymerase-1 ...... ls in Retina of Diabetic Rats.
@en
prefLabel
Poly(ADP-Ribose) Polymerase-1 ...... ls in Retina of Diabetic Rats.
@en
P2093
P2860
P1476
Poly(ADP-Ribose) Polymerase-1 ...... ls in Retina of Diabetic Rats.
@en
P2093
Artem A Tykhomyrov
Irina V Prischepa
Lesya V Yanitska
Mykhailo M Guzyk
Tamara M Kuchmerovska
Tatiana V Grinenko
Victor S Nedzvetsky
P2860
P2888
P304
P356
10.1007/S11064-016-1964-3
P577
2016-06-02T00:00:00Z